FDA Center for Drug Evaluation & Research Issues Warning Letter to Bertrand P. Cole, D.O.
February 19, 2026
February 19, 2026
WASHINGTON, Feb. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Bertrand P. Cole, D.O. from the Center for Drug Evaluation and Research:
* * *
Recipient: Bertrand P. Cole, D.O., 110 Corporate Drive, Suite 2, Portsmouth, NH 03801, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
FDA Ref. No.: 26-HFD-4 . . .
* * *
Recipient: Bertrand P. Cole, D.O., 110 Corporate Drive, Suite 2, Portsmouth, NH 03801, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
FDA Ref. No.: 26-HFD-4 . . .